Bullous Pemphigoid, a clinical case
DOI:
https://doi.org/10.24950/rspmi.1009Keywords:
Bullous pemphigoid, autoimmune subepidermal bullous dermatosisAbstract
Bullous Pemphigoid is the most common autoimmune blistering disease,
characterized by the presence of subepidermal blisters. The authors present a case control of bullous pemphigoid (generalized bullous form) in an
80-year-old-woman with diagnosis based on a careful anamnesis and examination, treated with systemic corticoid and tetracycline as well as local treatment, having been followed up for one year. Due to its high mortality
rate it is important to recognize and treat it as early as possible. A photographic follow-up and a brief review on this matter have been made with reference to some advances.
Downloads
References
Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJP, West J: Bullous pemphigoid and pemphigus vulgaris- incidence and mortality in the UK: population based cohort study. BMJ 2008; 337-a180.
Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK, Chen YC et al: Comorbidity profiles among patients with bullous pemphigoid: a nationwide population – based study. British Association of Dermatologists 2011; 165: 593-599.
Chan L, Bullous Pemphigoid, www.emedicine.com, 2011.
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Dlaporte E et al: Risk factors for bullous pemphigoid in the
elderly: a prospective case-control study. J Invest Dermatol 2010; 131:637-641.
Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C et al: Evaluation of clinical criteria for diagnosis of bullous pemphigoid. Arc Dermatology 1998; 134:1075-1080.
Goldstein B, Goldstein A, Pemphigus, www.uptodate.com, 2009.
Bernard P, Bullous pemphigoid,www.orphanet.com, 2006.
Southwell B, Riaz F, Khachemoune A, Bullous Pemphigoid: A Short Review, www.emedicine.com, 2009.
Wojnarowska F, Kirtschig G, Highet AS, Venning VA, Khumalo NP: Guidelines for the management of bullous pemphigoid.
Br J Dermatol 2002; 147: 214-221.
Joly P, Roujeau JC, BenichouJ, Picard C, Dreno B, Delaporte E et al: Comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Eng J Med 2002; 346:321-327.
Rzany B, Partscht K, Jung M, Kippers W, Mecking D, Baima B et al: Risk factors for lethal outcome in patients with bullous
pemphigoid. Arc Dermatology 2002; 138:903-908.
Yang YW, Chen YH, Xirasagar S, Lin HC: Increased risk of stroke in patients with bullous pemphigoid: a population-based follow- up study. Stroke 2011; 42:319-323.
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
